Jay D. Caplan's Insider Trades & SAST Disclosures
Jay D. Caplan's most recent trade in Fractyl Health Inc. was a trade of 179,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jay D. Caplan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 179,700 | 179,700 | - | - | Stock Option (right to buy) | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 104,400 | 104,400 | - | - | Stock Option (right to buy) | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 30 Jan 2025 | 22,346 | 175,890 | - | 1.7 | 37,988 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 30 Jan 2025 | 22,346 | 153,544 | - | 1.8 | 40,464 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 22,346 | 17,924 | - | - | Stock Option | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 30 Jan 2025 | 21,472 | 175,016 | - | 1.7 | 36,502 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 30 Jan 2025 | 21,472 | 153,544 | - | 1.9 | 41,802 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 21,472 | 40,270 | - | - | Stock Option | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2024 | 187,257 | 217,741 | - | 0 | Common Stock | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2024 | 187,257 | 0 | - | - | Restricted Stock Unit | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Sale of securities on an exchange or to another person at price $ 2.47 per share. | 10 Nov 2024 | 64,197 | 153,544 | - | 2.5 | 158,541 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 12 Sep 2024 | 95,484 | 95,484 | - | 1.7 | 162,323 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2024 | 95,484 | 0 | - | - | Stock Option | |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | Sale of securities on an exchange or to another person at price $ 2.90 per share. | 12 Sep 2024 | 65,000 | 30,484 | - | 2.9 | 188,474 | Common Stock |
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 177,726 | 0 | - | - | Series B Preferred Stock | ||
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 118,810 | 118,810 | - | - | Common Stock | ||
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 50,000 | 0 | - | - | Series A Preferred Stock | ||
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 44,730 | 0 | - | - | Series C-1 Preferred Stock | ||
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 32,514 | 0 | - | - | Series C-2 Preferred Stock | ||
| Fractyl Health Inc. | Jay D. Caplan | President, Chief Product Off. | 06 Feb 2024 | 23,299 | 358,806 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges